ESC 365 - How to approach a patient with HFimpEF

HFA Premium Access

How to approach a patient with HFimpEF

Session: Is left ventricular ejection fraction still relevant for guideline-directed medical therapy implementation?

Topic: Treatment

Speaker: Professor W. Mullens (Genk, BE)

Event: Heart Failure 2025

Congress Presentation

Add to my library

About the speaker

Professor Wilfried Mullens

Hospital Oost-Limburg (ZOL), Genk (Belgium)

114 presentations

118 followers

3 more presentations in this session

Broadening the scope: should we implement guideline-directed medical therapy across all left ventricular ejection fraction ranges?

Speaker: Professor B. Bozkurt (Houston, US)

New and emerging therapies for HFpEF

Speaker: Ms K. Cerlinskaite-Bajore (Vilnius, LT)

Is left ventricular ejection fraction still relevant for guideline-directed medical therapy implementation? - discussion

Access the full session

Is left ventricular ejection fraction still relevant for guideline-directed medical therapy implementation?

Speakers: Professor W. Mullens, Professor B. Bozkurt, Ms K. Cerlinskaite-Bajore

About the event

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress

ESC 365 is supported by

novartis

Explore sponsored resources